Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
alendronate	O
sodium	O
Attending:	O
___.	O
Chief	O
Complaint:	O
N/V,	O
mechanical	O
fall	B-Falls
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Therapeutic	O
paracentesis	O
on	O
___	O
Nasogastric	O
tube	O
placement	O
on	O
___	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
woman	O
with	O
metastatic	O
serous	O
carcinoma	O
of	O
likely	O
GYN	O
origin	O
presenting	O
with	O
abdominal	O
pain,	O
nausea/vomiting,	O
and	O
a	O
mechanical	O
fall.	B-Falls
She	O
reports	O
that	O
for	O
___	O
days	O
prior	O
to	O
admission,	O
she	O
was	O
having	O
abdominal	O
pain	O
and	O
constipation	B-Constipation
(no	O
bowel	O
movement	O
x4	O
days).	O
She	O
was	O
taking	O
limited	O
p.o.	O
over	O
that	O
time.	O
She	O
describes	O
a	O
band	O
of	O
pain	O
like	O
"twisting	O
intestines"	O
that	O
is	O
pulsatile/intermittent.	O
There	O
are	O
no	O
obvious	O
aggravating	O
or	O
alleviating	O
factors.	O
The	O
night	O
prior	O
to	O
admission	O
(___)	O
she	O
developed	O
nausea	O
and	O
had	O
a	O
small	O
bout	O
of	O
emesis;	O
the	O
morning	O
of	O
admission	O
she	O
had	O
emesis	B-Upper_gastrointestinal_haemorrhage
again	O
of	O
the	O
food	O
she	O
had	O
eaten.	O
No	O
blood	B-Upper_gastrointestinal_haemorrhage
noticed.	O
She	O
subsequently	O
slipped	O
in	O
her	O
own	O
emesis	O
with	O
a	O
head	O
strike	O
(no	O
loss	O
of	O
consciousness).	O
She	O
did	O
not	O
have	O
any	O
new	O
neurologic	O
symptoms.	O
She	O
has	O
had	O
no	O
fevers	O
or	O
chills.	O
In	O
the	O
ED,	O
initial	O
vitals	O
were:	O
98.4	O
|	O
87	O
|	O
108/60	O
|	O
18	O
|	O
100%	O
RA	O
Labs	O
were	O
notable	O
for:	O
9.2	O
>	O
11.1/36.1	O
<	O
205	O
(MCV	O
105)	O
142	O
|	O
100	O
|	O
28	O
Ca	O
9.1	O
--------------<	O
144	O
Mg	O
1.8	O
3.4	O
|	O
29	O
|	O
1.2	O
P	O
3.7	O
AST/ALT	O
___,	O
AP	O
55,	O
Tbili	O
0.5,	O
Alb	O
3.8	O
___	O
11.2,	O
___	O
24.7,	O
INR	O
1.0	O
Lactate	O
1.3	O
UA	O
bland	O
but	O
for	O
protein	O
and	O
10	O
ketones	O
Imaging	O
performed	O
included:	O
#	O
CT	O
A/P	O
with	O
contrast:	O
1.	O
Short	O
segment	O
of	O
small	O
bowel	O
wall	O
thickening	O
and	O
wall	O
edema	O
in	O
the	O
mid	O
abdomen	O
with	O
few	O
fluid	O
filled	O
loops	O
of	O
small	O
bowel,	O
most	O
compatible	O
with	O
enteritis.	O
2.	O
Redemonstration	O
of	O
large	O
volume	O
ascites.	O
3.	O
New	O
ground-glass	O
opacities	O
in	O
the	O
right	O
lower	O
lobe.	O
Correlate	O
clinically	O
for	O
aspiration	O
or	O
pneumonia.	B-Lower_respiratory_tract_infection
4.	O
Stable	O
dilation	O
of	O
the	O
main	O
pancreatic	O
duct	O
and	O
CBD	O
without	O
obstructing	O
lesion.	O
#	O
CT	O
C-spine	O
without	O
contrast:	O
1.	O
No	O
malalignment	O
or	O
fractures	O
a	O
sequela	O
of	O
trauma.	O
2.	O
Stable	O
multilevel	O
degenerative	O
changes	O
worse	O
at	O
C5-C6	O
and	O
C6-C7	O
levels.	O
#	O
CT	O
Head	B-Intracranial_haemorrhage
without	O
contrast:	O
1.	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
findings.	O
2.	O
Paranasal	O
sinus	O
disease.	O
The	O
patient	O
was	O
given:	O
500mg	O
LR	O
IV	O
40	O
mEq	O
potassium	O
4	O
mg	O
morphine	O
IV	O
4	O
mg	O
Zofran	O
IV	O
1	O
g	O
ceftriaxone	O
IV	O
500	O
mg	O
metronidazole	O
IV	O
Vitals	O
prior	O
to	O
transfer:	O
98.0	O
|	O
71	O
|	O
129/47	O
|	O
17	O
|	O
96%	O
RA	O
Upon	O
arrival	O
to	O
the	O
floor,	O
Ms.	O
___	O
confirmed	O
the	O
above	O
story	O
with	O
her	O
son	O
___	O
(son	O
___	O
also	O
at	O
bedside).	O
REVIEW	O
OF	O
SYSTEMS:	O
A	O
complete	O
10-point	O
review	O
of	O
systems	O
was	O
performed	O
and	O
was	O
negative	O
except	O
for	O
as	O
noted	O
in	O
the	O
HPI.	O
She	O
does	O
also	O
describe	O
chronic	O
increased	O
urinary	O
frequency	O
and	O
intermittent	O
incontinence	B-Urinary_incontinence
that	O
are	O
long-standing.	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY,	O
per	O
primary	O
oncologist	O
note:	O
Pt	O
reported	O
increasing	O
bloating	O
and	O
abdominal	O
pain	O
beginning	O
in	O
early	O
___	O
that	O
worsened	O
for	O
a	O
month.	O
She	O
was	O
seen	O
at	O
her	O
PCP's	O
office	O
on	O
___	O
at	O
which	O
point	O
TSH,	O
albumin,	O
LFTs	O
were	O
drawn	O
and	O
were	O
all	O
within	O
normal	O
limits.	O
She	O
underwent	O
an	O
abdominal	O
ultrasound	O
on	O
___	O
which	O
showed	O
large	O
volume	O
ascites	O
with	O
peritoneal	O
nodularity	O
visualized	O
within	O
the	O
pelvis	O
with	O
concern	O
for	O
ovarian	O
malignancy	O
or	O
other	O
primary.	O
She	O
had	O
a	O
follow	O
up	O
CT	O
abdomen/pelvis	O
on	O
___	O
which	O
showed	O
massive	O
ascites.	O
Neither	O
ovary	O
were	O
clearly	O
visualized	O
nor	O
was	O
the	O
appendix.	O
Peritoneal	O
nodularity	O
seen	O
on	O
US	O
was	O
not	O
clearly	O
identified	O
though	O
there	O
was	O
some	O
mild	O
hyperenhancement	O
of	O
the	O
inferior	O
peritoneal	O
surface	O
just	O
superior	O
to	O
the	O
bladder.	O
She	O
subsequently	O
had	O
a	O
therapeutic	O
paracentesis	O
on	O
___	O
with	O
evacuation	O
of	O
3L	O
of	O
fluid.	O
Cytology	O
report	O
showed	O
high	O
grade	O
serous	O
carcinoma	O
with	O
p53	O
showing	O
mutant	O
pattern	O
staining.	O
She	O
was	O
seen	O
by	O
OB/GYN	O
on	O
at	O
which	O
point	O
she	O
noted	O
the	O
fluid	O
appeared	O
to	O
be	O
recurring.	O
___	O
weight	O
gain	O
in	O
the	O
last	O
6mo.	O
She	O
has	O
a	O
history	O
of	O
leg	O
swelling	O
for	O
which	O
she	O
takes	O
lasix	O
30mg	O
QD.	O
She	O
was	O
recommended	O
tumor	O
markers	O
including	O
CA125,	O
CEA,	O
and	O
___	O
CT-Chest;	O
diagnostic	O
laparoscopy	O
to	O
assess	O
disease	O
extent	O
which	O
will	O
likely	O
be	O
followed	O
by	O
chemotherapy	O
with	O
a	O
possible	O
interval	O
cytoreductive	O
surgery	O
including	O
a	O
total	O
hysterectomy,	O
bilateral	O
salpingo-oophorectomy,	O
lymphadenectomy,	O
omentectomy,	O
and	O
removal	O
of	O
residual	O
disease.	O
Hearing	O
this	O
plan,	O
pt	O
expressed	O
interest	O
in	O
forgoing	O
surgery.	O
At	O
first	O
oncology	O
visit	O
on	O
___,	O
she	O
explained	O
her	O
greatest	O
source	O
of	O
discomfort	O
was	O
abdominal	O
pain/bloating.	O
We	O
recommended	O
CT	O
chest	O
to	O
complete	O
staging	O
and	O
a	O
visit	O
with	O
OB/GYN	O
to	O
discuss	O
the	O
role	O
for	O
surgical	O
management	O
of	O
her	O
disease.	O
___	O
C1D1	O
___	O
AUC	O
2	O
(day	O
1,	O
15)	O
___	O
C2D1	O
___	O
AUC	O
2	O
(day	O
1,	O
8)	O
___	O
C3D1	O
___	O
AUC	O
2	O
(d1,8)	O
___	O
C4D1	O
___	O
AUC	O
2	O
(d1,	O
15)	O
___	O
C5D1	O
___	O
AUC	O
2	O
(d1,	O
15)	O
___	O
C6d1	O
___	O
AUC	O
2	O
(d1,	O
15)	O
___	O
Break	O
from	O
chemotherapy;	O
CA125	O
had	O
plateaued	O
and	O
is	O
slightly	O
increased	O
today,	O
indicating	O
carboplatin	O
resistance.	O
Scans	O
overeall	O
had	O
improvd	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
HTN	O
-	O
HLD	O
-	O
IgA/IgG	O
pemphigus	O
foliaceous	O
(on	O
cellcept	O
and	O
low	O
dose	O
prednisone)	O
-	O
Positive	O
PPD,	O
neg	O
CXR	O
-	O
refused	O
INH	O
-	O
Chronic	O
___	O
edema	O
-	O
Postherpetic	O
neuralgia	O
-	O
Low	O
back	O
pain	O
-	O
DJD	O
on	O
LS-spine	O
XR	O
___	O
-	O
Osteoporosis	O
-	O
Plantar	O
Fasciitis	O
-	O
Cataracts	B-Visual_impairment
Social	O
History:	O
___	O
Family	O
History:	O
-	O
no	O
known	O
history	O
of	O
breast,	O
cervical,	O
endometrial,	O
uterine,	O
or	O
colon	O
CA	O
-	O
no	O
known	O
history	O
of	O
bleeding	O
or	O
clotting	O
disorder	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
=======================	O
VS:	O
97.9	O
|	O
120/80	O
|	O
87	O
|	O
18	O
|	O
96%RA	O
GENERAL:	O
Cachectic	B-Malnutrition
and	O
chronically	O
ill-appearing	O
woman,	O
nontoxic,	O
no	O
acute	O
distress	O
HEENT:	O
Normocephalic,	O
atraumatic,	O
approximately	O
3	O
x	O
3	O
cm	O
area	O
of	O
tenderness	O
to	O
palpation	O
over	O
posterior/temporal	O
left	O
region	O
(area	O
of	O
headstrike).	O
No	O
scleral	O
icterus,	O
no	O
conjunctival	O
pallor.	O
Dry	O
mucous	O
membranes.	O
Poor	O
dentition.	O
NECK:	O
No	O
concerning	O
lymphadenopathy	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
systolic	O
murmur	O
best	O
over	O
left	O
sternal	O
border	O
PULM:	O
Breathing	O
comfortably	O
on	O
room	O
air,	O
no	O
accessory	O
muscle	O
use,	O
lateral	O
fields	O
clear	O
ABD:	O
Distended,	O
normoactive	O
bowel	O
sounds,	O
tender	O
to	O
palpation	O
worse	O
in	O
the	O
right	O
upper	O
quadrant;	O
palpable	O
?Intestines	O
vs.	O
Mass	O
vs	O
hepatomegaly	O
to	O
4	O
fingerbreadths	O
below	O
costal	O
margin.	O
No	O
rebound	O
or	O
guarding.	O
EXT:	O
Warm,	O
well-perfused,	O
no	O
edema.	O
SKIN:	O
No	O
rashes/lesions.	O
Umbilicus	O
somewhat	O
dry/crusted.	O
NEURO:	O
Oriented	B-Delirium
to	O
"hospital,"	O
city,	O
___	O
Attentive	O
to	O
DOWB.	O
ACCESS:	O
Right	O
chest	O
port,	O
dressing	O
c/d/i	O
DICHARGE	O
PHYSICAL	O
EXAM	O
======================	O
VS:	O
T:	O
97.7	O
PO	O
BP:	O
154	O
/	O
77	O
HR:	O
86	O
RR:	O
16	O
SaO2:	O
95	O
RA	O
GENERAL:	O
Cachectic	B-Malnutrition
and	O
chronically	O
ill-appearing	O
woman,	O
sitting	O
upright	O
in	O
bed	O
HEENT:	O
Dry	O
mucous	O
membranes.	O
NGT	O
in	O
place	O
draining	O
bilious	O
fluid,	O
less	O
than	O
days	O
prior.	O
This	O
was	O
removed	O
just	O
prior	O
to	O
discharge	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
systolic	O
murmur	O
best	O
over	O
left	O
sternal	O
border	O
PULM:	O
Breathing	O
comfortably	O
on	O
room	O
air,	O
no	O
accessory	O
muscle	O
use,	O
clear	O
to	O
auscultation	O
bilaterally	O
ABD:	O
Soft,	O
non	O
distended,	O
nontender	O
throughout	O
without	O
rebound	O
or	O
guarding	O
EXT:	O
Warm,	O
trace	O
edema	O
SKIN:	O
Has	O
several	O
bruise-appearing	O
lesions	O
over	O
abdomen	O
related	O
to	O
pemphigus,	O
stable	O
per	O
patient	O
NEURO:	O
___	O
grossly	O
in	O
tact,	O
able	O
to	O
move	O
all	O
4	O
extremities	O
spontaneously	O
ACCESS:	O
Right	O
chest	O
port,	O
dressing	O
c/d/i	O
Pertinent	O
Results:	O
CYTOLOGY	O
FROM	O
PARACENTESIS	O
___:	O
Peritoneal	O
fluid:	O
POSITIVE	O
FOR	O
MALIGNANT	O
CELLS.	O
Consistent	O
with	O
adenocarcinoma	O
of	O
gynecologic	O
origin.	O
A	O
serous	O
ovarian	O
carcinoma	O
is	O
favored.	O
Note:	O
Immunohistochemistry	O
performed	O
shows	O
the	O
following	O
profile	O
in	O
the	O
tumor	O
cells:	O
Positive:	O
___,	O
B72.3,	O
PAX8,	O
CK7,	O
WT1	O
Negative:	O
CK20,	O
TTF-1,	O
CDX-2,	O
calretinin	O
ADMISSION	O
LABS	O
==============	O
___	O
11:30AM	O
BLOOD	O
WBC-9.2	O
RBC-3.44*	O
Hgb-11.1*	O
Hct-36.1	O
MCV-105*	O
MCH-32.3*	O
MCHC-30.7*	O
RDW-12.5	O
RDWSD-47.8*	O
Plt	O
___	O
___	O
11:30AM	O
BLOOD	O
Neuts-87.7*	O
Lymphs-5.0*	O
Monos-6.5	O
Eos-0.2*	O
Baso-0.2	O
Im	O
___	O
AbsNeut-8.06*	O
AbsLymp-0.46*	O
AbsMono-0.60	O
AbsEos-0.02*	O
AbsBaso-0.02	O
___	O
11:30AM	O
BLOOD	O
Glucose-144*	O
UreaN-28*	O
Creat-1.2*	O
Na-142	O
K-3.4*	O
Cl-100	O
HCO3-29	O
AnGap-13	O
___	O
11:30AM	O
BLOOD	O
ALT-10	O
AST-21	O
AlkPhos-55	O
TotBili-0.5	O
___	O
11:30AM	O
BLOOD	O
Lipase-28	O
___	O
11:30AM	O
BLOOD	O
Albumin-3.8	O
Calcium-9.1	O
Phos-3.7	O
Mg-1.8	O
___	O
11:45AM	O
BLOOD	O
Lactate-1.3	O
MICROBIOLOGY	O
============	O
___	O
11:30	O
am	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
4:20	O
pm	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
12:25	O
pm	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
MIXED	O
BACTERIAL	O
FLORA	O
(	O
>=	O
3	O
COLONY	O
TYPES),	O
CONSISTENT	O
WITH	O
SKIN	O
AND/OR	O
GENITAL	O
CONTAMINATION.	O
___	O
12:25PM	O
URINE	O
Color-Yellow	O
Appear-Clear	O
Sp	O
___	O
___	O
12:25PM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein-100*	O
Glucose-NEG	O
Ketone-10*	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.0	O
Leuks-NEG	O
___	O
12:25PM	O
URINE	O
RBC-2	O
WBC-3	O
Bacteri-NONE	O
Yeast-NONE	O
Epi-1	O
TransE-<1	O
___	O
12:25PM	O
URINE	O
CastHy-10*	O
___	O
12:25PM	O
URINE	O
Mucous-MANY*	O
IMAGING	O
=======	O
CT	O
ABDOMEN	O
AND	O
PELVIS	O
W	O
CONTRAST,	O
___:	O
1.	O
Short	O
segment	O
of	O
small	O
bowel	O
wall	O
thickening	O
and	O
wall	O
edema	O
in	O
the	O
mid	O
abdomen	O
with	O
few	O
fluid	O
filled	O
loops	O
of	O
small	O
bowel,	O
most	O
compatible	O
with	O
enteritis.	O
2.	O
Redemonstration	O
of	O
large	O
volume	O
ascites.	O
3.	O
New	O
ground-glass	O
opacities	O
in	O
the	O
right	O
lower	O
lobe.	O
Correlate	O
clinically	O
for	O
aspiration	O
or	O
pneumonia.	B-Lower_respiratory_tract_infection
4.	O
Stable	O
dilation	O
of	O
the	O
main	O
pancreatic	O
duct	O
and	O
CBD	O
without	O
obstructing	O
lesion.	O
KUB,	O
___:	O
1.	O
Mildly	O
dilated	O
loops	O
of	O
small	O
bowel	O
with	O
air-fluid	O
levels	O
in	O
the	O
absence	O
of	O
colonic	O
dilatation	O
suggest	O
partial	O
small	O
bowel	O
obstruction.	O
CT	O
may	O
be	O
performed	O
if	O
further	O
characterization	O
is	O
needed.	O
2.	O
Ascites	O
as	O
well	O
as	O
small	O
bilateral	O
pleural	O
effusions.	O
___	O
GUIDED	O
PARACENTESIS,	O
___:	O
1.	O
Technically	O
successful	O
ultrasound	O
guided	O
therapeutic	O
paracentesis.	O
2.	O
1.75	O
L	O
of	O
fluid	O
were	O
removed.	O
KUB,	O
___:	O
Unchanged	O
appearance	O
of	O
dilated	O
loops	O
of	O
fossa	O
bowel	O
with	O
air-fluid	O
levels	O
remain	O
concerning	O
for	O
small	O
bowel	O
obstruction.	O
KUB,	O
___:	O
Unchanged	O
appearance	O
of	O
dilated	O
loops	O
of	O
small	O
bowel	O
with	O
air-fluid	O
levels	O
consistent	O
with	O
a	O
partial	O
small-bowel	O
obstruction	O
when	O
compared	O
to	O
prior	O
radiograph	O
dated	O
___.	O
OTHER	O
PERTINENT	O
STUDIES	O
=======================	O
___	O
12:50PM	O
BLOOD	O
CA125-74*	O
___	O
05:24AM	O
BLOOD	O
TSH-0.89	O
___	O
05:24AM	O
BLOOD	O
Ret	O
Aut-2.6*	O
Abs	O
Ret-0.08	O
___	O
05:24AM	O
BLOOD	O
VitB12-1656*	O
Ferritn-286*	O
___	O
05:03AM	O
BLOOD	O
freeCa-1.09*	O
___	O
03:49AM	O
BLOOD	O
Triglyc-203*	O
DISCHARGE	O
LABS	O
==============	O
___	O
05:25AM	O
BLOOD	O
WBC-6.7	O
RBC-3.22*	O
Hgb-10.3*	O
Hct-33.4*	O
MCV-104*	O
MCH-32.0	O
MCHC-30.8*	O
RDW-12.2	O
RDWSD-46.4*	O
Plt	O
___	O
___	O
05:25AM	O
BLOOD	O
Glucose-143*	O
UreaN-8	O
Creat-0.8	O
Na-137	O
K-3.9	O
Cl-99	O
HCO3-27	O
AnGap-11	O
___	O
05:25AM	O
BLOOD	O
Calcium-7.7*	O
Phos-2.8	O
Mg-2.3	O
Brief	O
Hospital	O
Course:	O
SUMMARY:	O
___	O
year	O
old	O
woman	O
with	O
metastatic	O
serous	O
carcinoma	O
and	O
malignant	O
ascites	O
s/p	O
6	O
cycles	O
of	O
second	O
line	O
therapy	O
with	O
paclitaxel/carboplatin	O
(___)	O
who	O
presented	O
with	O
nausea/vomiting	O
and	O
constipation,	B-Constipation
found	O
to	O
have	O
a	O
malignant	O
partial	O
bowel	O
obstruction,	O
with	O
course	O
complicated	O
by	O
high	O
symptom	O
burden	O
and	O
malnutrition.	B-Malnutrition
On	O
___,	O
the	O
patient	O
and	O
her	O
family	O
requested	O
that	O
she	O
be	O
discharged	O
with	O
the	O
plan	O
to	O
go	O
to	O
the	O
___	O
emergency	O
department	O
in	O
order	O
to	O
seek	O
a	O
second	O
opinion.	O
While	O
we	O
support	O
patient	O
autonomy,	O
this	O
decision	O
occurred	O
against	O
medical	O
advice.	O
The	O
family	O
understands	O
the	O
risks	O
associated	O
with	O
leaving	O
the	O
hospital	O
at	O
this	O
time	O
though	O
this	O
continues	O
to	O
be	O
their	O
preference.	O
We	O
have	O
prepared	O
as	O
much	O
of	O
the	O
discharge	O
paperwork	O
as	O
able	O
in	O
an	O
effort	O
to	O
best	O
facilitate	O
the	O
remainder	O
of	O
her	O
care.	O
TRANSITIONAL	O
ISSUES:	O
Code	O
status:	O
Full	O
Contact:	O
___	O
-	O
___	O
Discharge	O
weight:	O
42.8	O
kg	O
#	O
High	O
grade	O
metastatic	O
serous	O
adenocarcinoma,	O
likely	O
from	O
the	O
ovary:	O
-	O
CA	O
125	O
(___):	O
76	O
-	O
Requesting	O
a	O
second	O
opinion	O
from	O
___	O
oncology	O
-	O
Ongoing	O
discussions	O
re:	O
code	O
status	O
and	O
goals	O
of	O
care	O
(recommending	O
discharge	O
to	O
hospice)	O
#	O
Bowel	O
obstruction:	O
-	O
Pt	O
and	O
family	O
requested	O
NGT	O
removal	O
___	O
-	O
We	O
recommend	O
placing	O
a	O
venting	O
G-tube	O
in	O
addition	O
to	O
percutaneous	O
peritoneal	O
pleurX	O
catheter	O
with	O
palliative	O
intent,	O
though	O
this	O
was	O
not	O
performed	O
given	O
family's	O
wishes	O
to	O
seek	O
a	O
second	O
opinion	O
-	O
If	O
able	O
to	O
tolerate	O
by	O
mouth,	O
will	O
continue	O
the	O
following:	O
--	O
Lansoprazole	O
30	O
mg	O
SL	O
once	O
daily	O
--	O
Dexamethasone	O
4	O
mg	O
PO	O
once	O
daily	O
-	O
*consider	O
down	O
titration	O
--	O
Oxycontin	O
10	O
mg	O
q12h	O
standing	O
+	O
hydromorphone	O
2	O
mg	O
PO	O
q4h:PRN	O
--	O
Zofran	O
ODT	O
8	O
mg	O
SL	O
q8h	O
PRN	O
nausea	O
--	O
Compazine	O
10	O
mg	O
PO	O
q8h	O
PRN	O
nausea	O
--	O
Lorazepam	O
___	O
mg	O
PO	O
PRN	O
nausea	O
--	O
Bisacodyl	O
suppositories	O
BID,	O
though	O
unlikely	O
to	O
take	O
at	O
home	O
#	O
Malignant	O
ascites:	O
-	O
___	O
require	O
repeat	O
therapeutic	O
paracentesis	O
(though	O
would	O
prefer	O
percutaneous	O
peritoneal	O
pleurX	O
placement)	O
#	O
IgA/IgG	O
pemphigus	O
foliaceus:	O
-	O
Continue	O
Mycophenolate	O
Mofetil	O
as	O
long	O
as	O
she	O
can	O
tolerate	O
PO	O
-	O
Holding	O
triamcinolone	O
and	O
betamethasone	O
cream	O
for	O
now	O
#	O
Holding	O
to	O
following	O
medications	O
(mainly	O
to	O
minimize	O
pill	O
burden),	O
though	O
can	O
restart	O
as	O
indicated:	O
-	O
Prednisone	O
5	O
mg	O
PO	O
once	O
daily	O
(in	O
exchange	O
for	O
dexamethasone	O
4	O
mg)	O
-	O
Metoprolol	O
succinate	O
XL	O
50	O
mg	O
once	O
daily	O
-	O
Simvastatin	O
20	O
mg	O
PO	O
QPM	O
-	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
daily	O
-	O
Multivitamin	O
PO	O
once	O
daily	O
-	O
Calcium	O
600	O
-	O
D3	O
400	O
unit	O
PO	O
BID	O
-	O
Docusate	O
sodium	O
100	O
mg	O
PO	O
BID	O
(held	O
iso	O
bowel	O
obstruction)	O
-	O
Polyethylene	O
Glycol	O
17	O
mg	O
PO	O
daily	O
(held	O
iso	O
bowel	O
obstruction)	O
ACTIVE	O
ISSUES:	O
#	O
Malignant	O
bowel	O
obstruction:	O
CT	O
scan	O
on	O
admission	O
was	O
suggestive	O
of	O
enteritis,	O
though	O
on	O
further	O
review	O
she	O
likely	O
had	O
a	O
bowel	O
obstruction.	O
Multiple	O
KUBs	O
show	O
stability	O
if	O
not	O
worsening	O
of	O
her	O
obstructive	O
process.	O
Treated	O
with	O
aggressive	O
bowel	O
regimen	O
(enemas,	O
suppositories)	O
along	O
with	O
octreotide,	O
dexamethasone	O
and	O
anti-emetics;	O
trialed	O
metoclopramide	O
with	O
minimal	O
effect.	O
NGT	O
placed	O
___	O
with	O
symptomatic	O
relief,	O
though	O
removed	O
___	O
per	O
family	O
and	O
patient	O
request.	O
Will	O
attempt	O
to	O
change	O
medications	O
from	O
IV	O
to	O
PO,	O
though	O
octreotide	O
will	O
have	O
to	O
be	O
discontinued.	O
Attempted	O
to	O
place	O
a	O
venting	O
G-tube	O
and	O
percutaneous	O
peritoneal	O
pleurx	O
with	O
___	O
though	O
given	O
family's	O
request	O
for	O
a	O
second	O
opinion,	O
this	O
was	O
not	O
performed	O
as	O
it	O
is	O
strictly	O
for	O
palliative	O
intent.	O
#	O
Metastatic	O
high	O
grade	O
serous	O
adenocarcinoma,	O
likely	O
ovarian:	O
#	O
Malignant	O
ascites:	O
Presented	O
in	O
___	O
with	O
ascites,	O
cytology	O
positive	O
for	O
high	O
grade	O
adenocarcinoma.	O
Imaging	O
has	O
been	O
unhelpful	O
in	O
terms	O
of	O
identifying	O
the	O
origin	O
of	O
her	O
disease,	O
though	O
per	O
outpatient	O
oncology	O
it	O
is	O
likely	O
from	O
the	O
ovary	O
and	O
she	O
has	O
peritoneal	O
disease	O
as	O
well.	O
She	O
is	O
s/p	O
6	O
cycles	O
of	O
paclitaxel	O
and	O
carboplatin	O
(ended	O
___,	O
though	O
this	O
was	O
stopped	O
given	O
concern	O
for	O
carboplatin	O
resistance	O
and	O
poor	O
functional	O
status.	O
As	O
above,	O
she	O
presented	O
with	O
nausea	O
and	O
vomiting,	O
found	O
to	O
have	O
a	O
bowel	O
obstruction	O
which	O
has	O
not	O
improved	O
despite	O
aggressive	O
management.	O
She	O
also	O
had	O
a	O
therapeutic	O
paracentesis	O
on	O
___	O
for	O
which	O
1.7L	O
was	O
drained.	O
Unfortunately,	O
due	O
to	O
her	O
severe	O
malnutrition,	B-Malnutrition
disease	O
progression	O
and	O
poor	O
functional	O
status,	O
we	O
recommended	O
against	O
further	O
chemotherapy	O
and	O
there	O
are	O
no	O
surgical	O
options	O
from	O
our	O
perspective	O
at	O
this	O
time.	O
Our	O
goal	O
would	O
be	O
to	O
send	O
her	O
to	O
home	O
hospice	O
vs	O
a	O
___	O
facility,	O
though	O
family	O
is	O
requesting	O
a	O
second	O
opinion	O
at	O
___.	O
Both	O
the	O
family	O
and	O
patient	O
have	O
been	O
informed	O
that	O
her	O
prognosis	O
is	O
poor	O
and	O
that	O
she	O
likely	O
has	O
weeks	O
to	O
live.	O
#	O
Malnutrition:	B-Malnutrition
Pt	O
presented	O
malnourished	B-Malnutrition
and	O
remains	O
severely	O
malnourished	B-Malnutrition
given	O
inability	O
to	O
take	O
PO	O
in	O
the	O
setting	O
of	O
a	O
persistent	O
bowel	O
obstruction.	O
We	O
opted	O
against	O
initiating	O
TPN	O
as	O
the	O
fluid	O
would	O
likely	O
cause	O
more	O
harm	O
and	O
accumulate	O
in	O
her	O
abdomen.	O
That	O
said,	O
she	O
was	O
continued	O
on	O
___	O
NS	O
at	O
75cc/hr	O
for	O
the	O
majority	O
of	O
her	O
hospital	O
stay.	O
CHRONIC	O
ISSUES:	O
#	O
IgA/IgG	O
pemphigus	O
foliaceus:	O
Held	O
home	O
prednisone	O
5	O
mg	O
in	O
exchange	O
for	O
Dexamethasone	O
4	O
mg	O
as	O
above.	O
Continued	O
Mycophenolate	O
Mofetil	O
as	O
an	O
IV	O
form,	O
will	O
transition	O
to	O
PO	O
at	O
discharge.	O
#	O
Macrocytic	O
anemia:	O
Hb	O
10.3	O
and	O
MCV	O
104	O
at	O
time	O
of	O
discharge.	O
Has	O
a	O
history	O
of	O
vitamin	O
B12	O
deficiency	O
though	O
this	O
has	O
been	O
appropriately	O
treated	O
(B12	O
now	O
>	O
1,000	O
on	O
recheck).	O
Peripheral	O
smear	O
showed	O
macroovalocytes.	O
This	O
may	O
be	O
secondary	O
to	O
folate	O
deficiency	O
but	O
is	O
more	O
likely	O
to	O
toxicity	O
from	O
chemotherapy	O
and	O
malnutrition.	B-Malnutrition
#	O
Hypertension:	O
SBPs	O
hovered	O
around	O
130-170s.	O
Did	O
not	O
treat	O
during	O
hospitalization.	O
#	O
Hyperglycemia:	O
AM	O
glucose	O
between	O
100s-140s,	O
did	O
not	O
require	O
insulin.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
2.	O
PredniSONE	O
5	O
mg	O
PO	O
DAILY	O
3.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
Second	O
Line	O
4.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
5.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
6.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
7.	O
betamethasone,	O
augmented	O
0.05	O
%	O
topical	O
BID	O
8.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Ointment	O
1	O
Appl	O
TP	O
BID	O
9.	O
Simvastatin	O
20	O
mg	O
PO	O
QPM	O
10.	O
Mycophenolate	O
Mofetil	O
1000	O
mg	O
PO	O
QAM	O
11.	O
Mycophenolate	O
Mofetil	O
500	O
mg	O
PO	O
QHS	O
12.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
13.	O
Calcium	O
600	O
+	O
D(3)	O
(calcium	O
carbonate-vitamin	O
D3)	O
600	O
mg(1,500mg)	O
-400	O
unit	O
oral	O
BID	O
14.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Bisacodyl	O
___ID:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
2.	O
Dexamethasone	O
4	O
mg	O
PO	O
DAILY	O
3.	O
HYDROmorphone	O
(Dilaudid)	O
2	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Severe	O
Reason	O
for	O
PRN	O
duplicate	O
override:	O
Alternating	O
agents	O
for	O
similar	O
severity	O
4.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
30	O
mg	O
PO	O
DAILY	O
5.	O
LORazepam	O
0.25	O
mg	O
PO	O
Q4H:PRN	O
nausea	O
6.	O
OxyCODONE	O
SR	O
(OxyCONTIN)	O
10	O
mg	O
PO	O
Q12H	O
7.	O
Mycophenolate	O
Mofetil	O
1000	O
mg	O
PO	O
QAM	O
8.	O
Mycophenolate	O
Mofetil	O
500	O
mg	O
PO	O
QHS	O
9.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
10.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
Second	O
Line	O
11.	O
HELD-	O
betamethasone,	O
augmented	O
0.05	O
%	O
topical	O
BID	O
Duration:	O
2	O
Weeks	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
betamethasone,	O
augmented	O
until	O
your	O
doctor	O
tells	O
you	O
to	O
do	O
so	O
12.	O
HELD-	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Polyethylene	O
Glycol	O
until	O
your	O
doctor	O
tells	O
you	O
it	O
is	O
safe	O
to	O
do	O
so	O
13.	O
HELD-	O
Triamcinolone	O
Acetonide	O
0.1%	O
Ointment	O
1	O
Appl	O
TP	O
BID	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Triamcinolone	O
Acetonide	O
0.1%	O
Ointment	O
until	O
your	O
doctor	O
tells	O
you	O
to	O
do	O
so	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
PRIMARY:	O
Malignant	O
bowel	O
obstruction	O
Metastatic	O
high	O
grade	O
serous	O
adenocarcinoma,	O
likely	O
ovarian	O
Malnutrition	B-Malnutrition
SECONDARY:	O
IgA/IgG	O
pemphigus	O
foliaceus	O
Macrocytic	O
anemia	O
Hypertension	O
Hyperglycemia	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
___,	O
You	O
were	O
admitted	O
to	O
___	O
because	O
you	O
were	O
having	O
abdominal	O
pain,	O
nausea	O
and	O
vomiting.	O
What	O
happened	O
in	O
the	O
hospital?	O
-	O
You	O
were	O
found	O
to	O
have	O
a	O
bowel	O
obstruction.	O
This	O
is	O
due	O
to	O
the	O
cancer	O
in	O
your	O
belly	O
-	O
You	O
were	O
given	O
several	O
medications	O
to	O
help	O
improve	O
the	O
obstruction,	O
but	O
unfortunately	O
it	O
did	O
not	O
help.	O
-	O
A	O
tube	O
was	O
inserted	O
into	O
your	O
nose	O
to	O
relieve	O
some	O
of	O
the	O
pressure	O
in	O
your	O
abdomen.	O
This	O
helped	O
your	O
symptoms	O
but	O
was	O
removed	O
prior	O
to	O
discharge.	O
-	O
You	O
underwent	O
a	O
procedure	O
to	O
remove	O
over	O
a	O
liter	O
of	O
fluid	O
in	O
your	O
belly.	O
This	O
fluid	O
is	O
called	O
ascites	O
and	O
is	O
due	O
to	O
your	O
cancer.	O
What	O
should	O
I	O
do	O
when	O
I	O
go	O
home?	O
-	O
We	O
have	O
made	O
changes	O
to	O
your	O
medication	O
list,	O
so	O
please	O
take	O
your	O
medications	O
as	O
prescribed.	O
-	O
We	O
also	O
recommend	O
that	O
you	O
use	O
the	O
bisacodyl	O
suppositories	O
two	O
time	O
a	O
day	O
to	O
help	O
with	O
your	O
constipation	B-Constipation
and	O
relieve	O
pressure	O
from	O
below	O
-	O
Please	O
go	O
to	O
your	O
follow	O
up	O
appointments	O
listed	O
below	O
-	O
We	O
recommend	O
that	O
you	O
call	O
your	O
oncologist,	O
Dr.	O
___	O
at	O
___	O
to	O
schedule	O
a	O
sooner	O
appointment	O
in	O
the	O
next	O
___	O
weeks	O
-	O
If	O
you	O
develop	O
symptoms	O
of	O
nausea,	O
vomiting	O
or	O
severe	O
abdominal	O
pain,	O
please	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
emergency	O
room.	O
It	O
was	O
a	O
pleasure	O
taking	O
part	O
in	O
your	O
care.	O
We	O
wish	O
you	O
all	O
the	O
best.	O
Sincerely,	O
The	O
team	O
at	O
___	O
Followup	O
Instructions:	O
___	O

